Physician profile
Cory E Bennett
NPI 1184068249
$1,778.98
in general payments reported to CMS, 2019-2025
28 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $159 · 2021: $192 · 2022: $202 · 2023: $426 · 2024: $171 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $256.50 | 2019-2023 | Orilissa, Lo Loestrin Fe, Ubrelvy |
| Hologic Sales and Service, LLC | $235.58 | 2019-2025 | Acessa Provu System, Aptima, Novasure |
| Pfizer INC. | $144.66 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $134.68 | 2023-2025 | Myfembree |
| Organon LLC | $123.90 | 2021-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $95.00 | 2023-2025 | |
| Astellas Pharma US INC | $89.50 | 2019-2024 | Veozah |
| Ethicon US, LLC | $70.65 | 2020 | |
| Minerva Surgical, INC | $68.54 | 2019-2021 | |
| Millicent US INC | $59.00 | 2025 | Intrarosa, Femlyv |
| Merck Sharp & Dohme LLC | $52.83 | 2019-2020 | |
| Amgen INC. | $51.15 | 2019-2025 | Evenity |
| Exeltis, USA INC. | $40.62 | 2019-2023 | Slynd |
| Therapeuticsmd, INC. | $39.82 | 2019 | |
| Amag Pharmaceuticals, INC. | $38.75 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $38.56 | 2019-2023 | |
| Ascend Therapeutics US, LLC | $36.05 | 2019 | |
| Aspira Women'S Health INC | $29.75 | 2022 | |
| Shield Therapeutics INC | $28.88 | 2023-2025 | Accrufer |
| Gynesonics, INC. | $24.68 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exact Sciences Corporation | $18.46 | 2023 | Cologuard Collection Kit |
| Boston Scientific Corporation | $17.53 | 2023 | |
| Gilead Sciences, INC. | $17.44 | 2022 | |
| Optumhealth Care Solutions, LLC | $15.21 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Medicem INC. | $14.08 | 2020 | |
| Duchesnay USA Incorporated | $13.66 | 2019 | |
| Lupin INC. | $12.50 | 2019 | |
| Bard Access Systems, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.